Skip to main navigation Skip to search Skip to main content

555 - Contrast enhanced ultrasound for the localization of prostate cancer – correlation with radical prostatectomy specimens

Research output: Contribution to journal › Conference article › peer-review

Abstract

Introduction & Objectives: Trans Rectal UltraSound (TRUS) is an affordable, portable and safe imaging platform well known to the urologist for prostate imaging. However, prostate cancer (PCa) cannot be visualized with Greyscale TRUS. In Contrast-Enhanced UltraSound (CEUS), an intravenous Ultrasound Contrast Agent (UCA) consisting of gas filled microbubbles is used to visualize PCa-associated vascular anomalies. Contrast-ultrasound dispersion imaging (CUDI) analyses the UCA dispersion patterns as the UCA spreads through the prostate, with the intention to objectify and simplify the interpretation of CEUS. The aim was to determine the value of 2D CEUS imaging and the additional value of CUDI derived parametric maps for the localization of significant PCa.
Original languageEnglish
Pages (from-to)e739-e740
Number of pages2
JournalEuropean Urology Supplements
Volume18
Issue number1
DOIs
Publication statusPublished - Mar 2019
Event34th Annual EAU Congress European Association of Urology (EAU19) - Fira Gran Via, Barcelona, Spain
Duration: 15 Mar 2019 → 19 Mar 2019
https://eaucongress.uroweb.org/

Bibliographical note

Abstracts EAU19 – 34th Annual EAU Congress

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of '555 - Contrast enhanced ultrasound for the localization of prostate cancer – correlation with radical prostatectomy specimens'. Together they form a unique fingerprint.

Cite this